Eli Lilly and Company (LLY): A Bull Case Theory

We came across a bullish thesis on Eli Lilly and Company (LLY) on Business Model Mastery’s Substack. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company (LLY)'s share was trading at $765.68 as of 5^th June. LLY’s trailing and forward P/E were 62.30 and 35.09 respectively according to Yahoo Finance.

[caption id="attachment_1205351" align="aligncenter" width="768"] A picture of a pharma technician preparing an IV injection of a biopharmaceutical product.[/caption]

Eli Lilly is no longer just a pharmaceutical giant—it’s becoming a platform...